Supporting the

Neuroendocrine Cancer Community

Assessment of major gaps

Dec 19, 2019

Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals.

Due to the increasing incidence and prevalence of neuroendocrine tumors (NETs), there is a need to assess any gaps in awareness and care. A survey was undertaken in 2017 to identify perceived unmet needs from the perspectives of patients/families, patient advocates and health care professionals (HCPs). The survey consisted of 33–37 questions (depending on type of respondent) across four areas: information, care, treatments and research.

Recent News

PERT Update: Addressing Current Shortages

PERT Update: Addressing Current Shortages

At Neuroendocrine Cancer UK, we have been actively collaborating with our charity partners to tackle the urgent need to resolve the ongoing shortages of Pancreatic Enzyme Replacement Therapy (PERT). Our joint efforts have resulted in significant strides towards...

read more
June Highlights

June Highlights

Thanks to you, this is what we have been able to achieve this month. - -   🎉 June Highlights! 🎉 💊 We've been working...

read more
Announcing the 2024 Pump-Priming Grant Winner

Announcing the 2024 Pump-Priming Grant Winner

As part of our ‘Advancing Neuroendocrine Cancer Research’ campaign, and in collaboration with the United Kingdom & Ireland Neuroendocrine Tumour Society (UKINETS) we are funding one pump-priming grant in 2024. This grant aims to provide pump-priming funds to...

read more